Episode 160: NASDAQ $GNPX is Advancing Cancer and Diabetes Treatments

In this exclusive Global One Media interview, Genprex, Inc. (NASDAQ: GNPX) Chief Financial Officer Ryan M. Confer delves into his company's groundbreaking work so far in clinical-stage gene therapy. Mr. Confer explains how Genprex's technologies have been designed to address the needs of large patient populations with cancer and diabetes who currently have limited treatment options and talks about the firm’s upcoming milestones. Learn more about Genprex by visiting their website: https://www.genprex.com/ Watch the full YouTube interview here: https://www.youtube.com/watch?v=PQT-M_khrXw And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1